public1.jpgpublic2.jpg

PUBBLICAZIONI SCIENTIFICHE SELEZIONATE PRODOTTE DAI COMPONENTI DELLA
LUPUS CLINIC
SUL LUPUS ERITEMATOSO SISTEMICO E
SULLA SINDROME DA ANTICORPI ANTIFOSFOLIPIDI
 

PUBBLICAZIONI PIU' RECENTI (2010-2013, in neretto i componenti della LCRomaSapienza)
 
 
  1. Conti F, Ceccarelli F, Massaro L, Pacucci VA, Miranda F, Truglia S, Cipriano E, Martinelli F, Leccese I, Spinelli FR, Alessandri C, Perricone C, Valesini G. Evaluation of the Patient Acceptable Symptom State (PASS) in Italian Patients Affected by Systemic Lupus Erythematosus: Association with Disease Activity Indices. PLoS One. 2013 Sep 9;8(9):e73517. doi: 10.1371/journal.pone.0073517. PubMed PMID: 24039971; PubMed Central PMCID: PMC3767687.   
  2. Perricone C, Shoenfeld Y. Hepatitis B vaccination and undifferentiated connective tissue disease: another brick in the wall of the autoimmune/inflammatory syndrome induced by adjuvants (Asia). J Clin Rheumatol. 2013 Aug;19(5):231-3. doi: 10.1097/RHU.0b013e31829d56f1. PubMed PMID: 23884184.  
  3. Perricone C, Ciccacci C, Ceccarelli F, Di Fusco D, Spinelli FR, Cipriano E, Novelli G, Valesini G, Conti F, Borgiani P. TRAF3IP2 gene and systemic lupus erythematosus: association with disease susceptibility and pericarditis development. Immunogenetics. 2013 Oct;65(10):703-9. doi:10.1007/s0-251-013-0717-6. Epub 2013 Jul 9. PubMed PMID: 23836313.  
  4. Colafrancesco S, Agmon-Levin N, Perricone C, Shoenfeld Y. Unraveling the soul  of autoimmune diseases: pathogenesis, diagnosis and treatment adding dowels to the puzzle. Immunol Res. 2013 Jul;56(2-3):200-5. doi: 10.1007/s12026-013-8429-4.   
  5. Perricone C, Agmon-Levin N, Colafrancesco S, Shoenfeld Y. Vitamins and systemic lupus erythematosus: to D or not to D. Expert Rev Clin Immunol. 2013 May;9(5):397-9. doi: 10.1586/eci.13.23. PubMed PMID: 23634733.   
  6. Ballanti E, Perricone C, Greco E, Ballanti M, Di Muzio G, Chimenti MS, Perricone R. Complement and autoimmunity. Immunol Res. 2013 Jul;56(2-3):477-91. doi: 10.1007/s12026-013-8422-y. PubMed PMID: 23615835.   
  7. Perricone C, Agmon-Levin N, Ceccarelli F, Valesini G, Anaya JM, Shoenfeld Y. Genetics and autoantibodies. Immunol Res. 2013 Jul;56(2-3):206-19. doi: 10.1007/s12026-013-8396-9. PubMed PMID: 23564181.
  8. Perricone C, Agmon-Levin N, Shoenfeld Y. Novel pebbles in the mosaic of autoimmunity. BMC Med. 2013 Apr 4;11:101. doi: 10.1186/1741-7015-11-101. PubMed PMID: 23557479; PubMed Central PMCID: PMC3635901.
  9. Perricone C, Shoenfeld N, Agmon-Levin N, de Carolis C, Perricone R, Shoenfeld Y. Smell and autoimmunity: a comprehensive review. Clin Rev Allergy Immunol. 2013 Aug;45(1):87-96. doi: 10.1007/s12016-012-8343-x. PubMed PMID: 23233263.  
  10. Frisenda S, Perricone C, Valesini G. Cartilage as a target of autoimmunity: a thin layer. Autoimmun Rev. 2013 Mar;12(5):591-8. doi:10.1016/j.autrev.2012.10.003. Epub 2012 Nov 30. PubMed PMID: 23201917.  
  11. Conti F, Ceccarelli F, Perricone C, Miranda F, Truglia S, Massaro L, Pacucci  VA, Conti V, Bartosiewicz I, Spinelli FR, Alessandri C, Valesini G. Flare, persistently active disease, and serologically active clinically quiescent disease in systemic lupus erythematosus: a 2-year follow-up study. PLoS One. 2012;7(9):e45934. doi: 10.1371/journal.pone.0045934. Epub 2012 Sep 21. PubMed PMID: 23029327; PubMed Central PMCID: PMC3448702.  
  12. Conti F, Alessandri C, Perricone C, Scrivo R, Rezai S, Ceccarelli F, Spinelli FR, Ortona E, Marianetti M, Mina C, Valesini G. Neurocognitive dysfunction in systemic lupus erythematosus: association with antiphospholipid antibodies, disease activity and chronic damage. PLoS One. 2012;7(3):e33824. doi:10.1371/journal.pone.0033824. Epub 2012 Mar 26. PubMed PMID: 22461897; PubMed Central PMCID: PMC3312889.   
  13. Perricone C, de Carolis C, Perricone R. Pregnancy and autoimmunity: a common problem. Best Pract Res Clin Rheumatol. 2012 Feb;26(1):47-60. doi: 10.1016/j.berh.2012.01.014. Review. PubMed PMID: 22424192.
  14. Perricone C, Agmon-Levin N, Valesini G, Shoenfeld Y. Vaccination in patients  with chronic or autoimmune rheumatic diseases: the ego, the id and the superego.  Joint Bone Spine. 2012 Jan;79(1):1-3. doi: 10.1016/j.jbspin.2011.10.006. Epub 2011 Nov 26. PubMed PMID: 22119345.   
  15. Perricone C, Alessandri C, Valesini G. ['ASIA' - Autoimmune/inflammatory syndrome induced by adjuvants: even and odd]. Reumatismo. 2011;63(2):63-6. Italian. PubMed PMID: 21776441.  
  16. Perricone R, Perricone C, Shoenfeld Y. Autoimmunity: when the immune system becomes the self-ish giant. Autoimmun Rev. 2011 Aug;10(10):575-6. doi: 10.1016/j.autrev.2011.05.003. Epub 2011 May 18. PubMed PMID: 21621001.  
  17. Conti F, Ceccarelli F, Perricone C, Alessandri C, Conti V, Massaro L, Truglia S, Spinelli FR, Spadaro A, Valesini G. Rituximab infusion-related adverse event rates are lower in patients with systemic lupus erythematosus than in those with  rheumatoid arthritis. Rheumatology (Oxford). 2011 Jun;50(6):1148-52. doi: 10.1093/rheumatology/keq436. Epub 2011 Jan 28. PubMed PMID: 21278072.   
  18. Conti F, Perricone C, Ceccarelli F, Valesini G. Rituximab treatment of systemic lupus erythematosus in controlled trials and in clinical practice: Two sides of the same coin. Autoimmun Rev. 2010 Sep;9(11):716-20. doi: 10.1016/j.autrev.2010.07.013. Epub 2010 Jul 25. PubMed PMID: 20667484.  
  19. Conti F, Ceccarelli F, Perricone C, Massaro L, Spinelli FR, Valesini G. Low incidence of flare and persistent active disease in a cohort of Italian patients  with systemic lupus erythematosus: comment on the article by Nikpour et al. Arthritis Care Res (Hoboken). 2010 Jun;62(6):899-900; author reply 900. doi: 10.1002/acr.20145. PubMed PMID: 20535803.   
  20. Iannuccelli C, Spinelli FR, Guzzo MP, Priori R, Conti F, Ceccarelli F, Pietropaolo M, Olivieri M, Minniti A, Alessandri C, Gattamelata A, Valesini G, Di Franco M. Fatigue and widespread pain in systemic lupus erythematosus and Sjögren's syndrome: symptoms of the inflammatory disease or associated fibromyalgia? Clin Exp Rheumatol. 2012 Nov-Dec;30(6 Suppl 74):117-21. Epub 2012 Dec 14. PubMed PMID: 23261010.   
  21. Colasanti T, Alessandri C, Capozzi A, Sorice M, Delunardo F, Longo A, Pierdominici M, Conti F, Truglia S, Siracusano A, Valesini G, Ortona E, Margutti  P. Autoantibodies specific to a peptide of β2-glycoprotein I cross-react with TLR4, inducing a proinflammatory phenotype in endothelial cells and monocytes. Blood. 2012 Oct 18;120(16):3360-70. doi: 10.1182/blood-2011-09-378851. Epub 2012 Aug 29. PubMed PMID: 22932793.   A
  22. Alessandri C, Barbati C, Vacirca D, Piscopo P, Confaloni A, Sanchez M, Maselli A, Colasanti T, Conti F, Truglia S, Perl A, Valesini G, Malorni W, Ortona E, Pierdominici M. T lymphocytes from patients with systemic lupus erythematosus are resistant to induction of autophagy. FASEB J. 2012 Nov;26(11):4722-32. doi: 10.1096/fj.12-206060. Epub 2012 Jul 26. PubMed PMID: 22835828; PubMed Central PMCID: PMC3475261.   
  23. Conti F, Alessandri C, Sorice M, Capozzi A, Longo A, Garofalo T, Misasi R, Bompane D, Hughes GR, Khamashta MA, Valesini G. Thin-layer chromatography immunostaining in detecting anti-phospholipid antibodies in seronegative anti-phospholipid syndrome. Clin Exp Immunol. 2012 Mar;167(3):429-37. doi: 10.1111/j.1365-2249.2011.04532.x. PubMed PMID: 22288586; PubMed Central PMCID: PMC3374275.  
  24. Govoni M, Bombardieri S, Bortoluzzi A, Caniatti L, Casu C, Conti F, De Vita S, Doria A, Farina I, Ferraccioli G, Gremese E, Mansutti E, Mosca M, Padovan M, Piga M, Tincani A, Tola MR, Tomietto P, Taglietti M, Trotta F, Valesini G, Zen M, Mathieu A; Italian Society of Rheumatology. Factors and comorbidities associated  with first neuropsychiatric event in systemic lupus erythematosus: does a risk profile exist? A large multicentre retrospective cross-sectional study on 959 Italian patients. Rheumatology (Oxford). 2012 Jan;51(1):157-68. doi: 10.1093/rheumatology/ker310. Epub 2011 Nov 10. PubMed PMID: 22075066.   
  25. Cervera R, Conti F, Doria A, Iaccarino L, Valesini G. Does seronegative antiphospholipid syndrome really exist? Autoimmun Rev. 2012 Jun;11(8):581-4. doi: 10.1016/j.autrev.2011.10.017. Epub 2011 Oct 22. Review. PubMed PMID: 22036830.
  26.  Colasanti T, Maselli A, Conti F, Sanchez M, Alessandri C, Barbati C, Vacirca  D, Tinari A, Chiarotti F, Giovannetti A, Franconi F, Valesini G, Malorni W, Pierdominici M, Ortona E. Autoantibodies to estrogen receptor α interfere with T  lymphocyte homeostasis and are associated with disease activity in systemic lupus erythematosus. Arthritis Rheum. 2012 Mar;64(3):778-87. doi: 10.1002/art.33400. PubMed PMID: 21968947.   
  27. Alessandri C, Conti F, Pendolino M, Mancini R, Valesini G. New autoantigens in the antiphospholipid syndrome. Autoimmun Rev. 2011 Aug;10(10):609-16. doi: 10.1016/j.autrev.2011.04.011. Epub 2011 Apr 27. Review. PubMed PMID: 21545849. 
  28. Valesini G, Conti F. The persistent challenge of lupus nephritis. Clin Rev Allergy Immunol. 2011 Jun;40(3):135-7. doi: 10.1007/s12016-010-8210-6. PubMed PMID: 20811786.   
  29.  Ortona E, Capozzi A, Colasanti T, Conti F, Alessandri C, Longo A, Garofalo T, Margutti P, Misasi R, Khamashta MA, Hughes GR, Valesini G, Sorice M. Vimentin/cardiolipin complex as a new antigenic target of the antiphospholipid syndrome. Blood. 2010 Oct 21;116(16):2960-7. doi: 10.1182/blood-2010-04-279208. Epub 2010 Jul 15. PubMed PMID: 20634382.  
  30.  Conti F, Spinelli FR, Alessandri C, Valesini G. Toll-like receptors and lupus nephritis. Clin Rev Allergy Immunol. 2011 Jun;40(3):192-8. doi: 10.1007/s12016-010-8208-0. Review. PubMed PMID: 20596796.  
  31. Profumo E, Buttari B, Alessandri C, Conti F, Capoano R, Valesini G, Salvati B, Riganò R. Beta2-glycoprotein I is a target of T cell reactivity in patients with advanced carotid atherosclerotic plaques. Int J Immunopathol Pharmacol. 2010 Jan-Mar;23(1):73-80. PubMed PMID: 20377996.  
  32.  Alessandri C, Conti F, Conigliaro P, Mancini R, Massaro L, Valesini G. Seronegative autoimmune diseases. Ann N Y Acad Sci. 2009 Sep;1173:52-9. doi: 10.1111/j.1749-6632.2009.04806.x. PubMed PMID: 19758132.     
  33. Mosca M, Govoni M, Tomietto P, Aringer M, Boumpas D, Cervera R, Conti F, D'Cruz D, Doria A, De La Fuente D, Galeazzi M, Houssiau F, Huizinga TW, Khamashta MA, Ines L, Duarte C, Couto M, Meroni P, Montecucco C, Norkuviene E, Riemekasten  G, Rios V, Schneider M, Shoenfeld Y, Steup-Beekman GM, Szmyrka-Kaczmarek M, Tani  C, Tincani A, Tzioufas AG, Voll R, Bencivelli W, Salaffi F, Bombardieri S. The development of a simple questionnaire to screen patients with SLE for the presence of neuropsychiatric symptoms in routine clinical practice. Lupus. 2011 Apr;20(5):485-92. doi: 10.1177/0961203310389097. Epub 2011 Feb 21. PubMed PMID: 21339241.   
  34. Priori R, Gattamelata A, d'Amati G, Giordano C, Piccioni MG, Valesini G, Framarino-dei-Malatesta M. Myopathy complicating lupus pregnancy. J Clin Rheumatol. 2013 Apr;19(3):132-3. doi: 10.1097/RHU.0b013e318289dbbe. PubMed PMID:  23519179.   
  35. Čučnik S, Kveder T, Artenjak A, Ulcova Gallova Z, Swadzba J, Musial J, Iwaniec T, Stojanovich L, Alessandri C, Valesini G, Avčin T, Cohen Tervaert JW, Rozman B, Božič B. Avidity of anti-β2-glycoprotein I antibodies in patients with antiphospholipid syndrome. Lupus. 2012 Jun;21(7):764-5. doi:10.1177/0961203312440057. PubMed PMID: 22635226.   
  36. Cucnik S, Kveder T, Ulcova-Gallova Z, Swadzba J, Musial J, Valesini G, Avcin T, Rozman B, Bozic B. The avidity of anti-beta2-glycoprotein I antibodies in patients with or without antiphospholipid syndrome: a collaborative study in the frame of the European forum on antiphospholipid antibodies. Lupus. 2011 Oct;20(11):1166-71. doi: 10.1177/0961203311406308. Epub 2011 Jun 28. Erratum in:  Lupus. 2011 Dec;20(14):1569. Ulcova, G Z [corrected to Ulcova-Gallova, Z]. PubMed PMID: 21712304.   
  37.   Turi MC, D'Urbano M, Celletti E, Alessandri C, Valesini G, Paganelli R. Serum sFas/sFasL ratio in systemic lupus erythematosus (SLE) is a function of age. Arch Gerontol Geriatr. 2009;49 Suppl 1:221-6. doi: 10.1016/j.archger.2009.09.032. PubMed PMID: 19836636.
 
 
 
 

PUBBLICAZIONI
  • Ossandon A, Iagnocco A, Alessandri C, Priori R, Conti F, Valesini G. Ultrasonographic depiction of knee joint alterations in systemic lupus erythematosus. Clin Exp Rheumatol. 2009 Mar-Apr;27(2):329-32. PubMed PMID: 19473577.
  • Margutti P, Matarrese P, Conti F, Colasanti T, Delunardo F, Capozzi A, Garofalo T, Profumo E, Riganò R, Siracusano A, Alessandri C, Salvati B, Valesini G, Malorni W, Sorice M, Ortona E. Autoantibodies to the C-terminal subunit of RLIP76 induce oxidative stress and endothelial cell apoptosis in immune-mediated  vascular diseases and atherosclerosis. Blood. 2008 May 1;111(9):4559-70. Epub 2007 Nov 9. PubMed PMID: 17993611.
  • Perricone R, De Carolis C, KrOegler B, Greco E, Giacomelli R, Cipriani P, Fontana L, Perricone C. Intravenous immunoglobulin therapy in pregnant patients affected with systemic lupus erythematosus and recurrent spontaneous abortion. Rheumatology (Oxford). 2008 May;47(5):646-51. Epub 2008 Mar 17. PMID: 18346976.
  • Perricone R, Perricone C, De Carolis C, Shoenfeld Y. NK cells in autoimmunity: a two-edg'd weapon of the immune system. Autoimmun Rev. 2008 May;7(5):384-90. Epub 2008 Mar 31. Review. PMID: 18486926.
  • Atzeni F, Bendtzen K, Bobbio-Pallavicini F, Conti F, Cutolo M, Montecucco C, Sulli A, Valesini G, Sarzi-Puttini P. Infections and treatment of patients with rheumatic diseases. Clin Exp Rheumatol. 2008 Jan-Feb;26(1 Suppl 48):S67-73. Review. PubMed PMID: 18570757.
  • Sorice M, Longo A, Capozzi A, Garofalo T, Misasi R, Alessandri C, Conti F, Buttari B, Riganò R, Ortona E, Valesini G. Anti-beta2-glycoprotein I antibodies induce monocyte release of tumor necrosis factor alpha and tissue factor by signal transduction pathways involving lipid rafts. Arthritis Rheum. 2007 Aug;56(8):2687-97. PubMed PMID: 17665396.
  • Perricone C, De Carolis C, Giacomelli R, Zaccari G, Cipriani P, Bizzi E, Perricone R. High levels of NK cells in the peripheral blood of patients affected with anti-phospholipid syndrome and recurrent spontaneous abortion: a potential new hypothesis. Rheumatology (Oxford). 2007 Oct;46(10):1574-8. Epub 2007 Aug 17. PMID: 17704519.
  • Diamanti AP, Rosado MM, Carsetti R, Valesini G. B cells in SLE: different biological drugs for different pathogenic mechanisms. Autoimmun Rev. 2007 Dec;7(2):143-8. Epub 2007 Mar 22. Review. PubMed PMID: 18035325.
  • Alessandri C, Sorice M, Bombardieri M, Conigliaro P, Longo A, Garofalo T, Manganelli V, Conti F, Esposti MD, Valesini G. Antiphospholipid reactivity against cardiolipin metabolites occurring during endothelial cell apoptosis. Arthritis Res Ther. 2006;8(6):R180. PubMed PMID: 17150088.
  • Alessandri C, Bombardieri M, Valesini G. Pathogenic mechanisms of anti-endothelial cell antibodies (AECA): their prevalence and clinical relevance. Adv Clin Chem. 2006;42:297-326. Review. PubMed PMID: 17131630.
  • Valesini G, Alessandri C, Celestino D, Conti F. Anti-endothelial antibodies and neuropsychiatric systemic lupus erythematosus. Ann N Y Acad Sci. 2006 Jun;1069:118-28. Review. PubMed PMID: 16855139.
  • Ossandon A, Bompane D, Alessandri C, Marocchi E, Conti F, Valesini G. Leishmania in SLE mimicking an exacerbation. Clin Exp Rheumatol. 2006 Mar-Apr;24(2):186-90. PubMed PMID: 16762157.
  • Riccieri V, Spadaro A, Ceccarelli F, Scrivo R, Germano V, Valesini G. Nailfold capillaroscopy changes in systemic lupus erythematosus: correlations with disease activity and autoantibody profile. Lupus. 2005;14(7):521-5. PubMed PMID: 16130507.
  • Margutti P, Sorice M, Conti F, Delunardo F, Racaniello M, Alessandri C, Siracusano A, Riganò R, Profumo E, Valesini G, Ortona E. Screening of an endothelial cDNA library identifies the C-terminal region of Nedd5 as a novel autoantigen in systemic lupus erythematosus with psychiatric manifestations. Arthritis Res Ther. 2005;7(4):R896-903. Epub 2005 May 20. PubMed PMID: 15987492; PubMed Central PMCID: PMC1175040
  • Stefanutti C, Vivenzio A, Di Giacomo S, Mareri M, Ceccarelli F, Valesini G. Cyclophosphamide and immunoadsorption apheresis treatment of lupus nephritis nonresponsive to drug therapy alone. BioDrugs. 2005;19(2):129-33. PubMed PMID: 15807630.
  • Alessandri C, Bombardieri M, Di Prospero L, Conigliaro P, Conti F, Labbadia G, Misasi R, Sorice M, Valesini G. Anti-lysobisphosphatidic acid antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus. Clin Exp Immunol. 2005 Apr;140(1):173-80. PubMed PMID: 15762889.
  • Sorice M, Circella A, Cristea IM, Garofalo T, Di Renzo L, Alessandri C, Valesini G, Esposti MD. Cardiolipin and its metabolites move from mitochondria to other cellular membranes during death receptor-mediated apoptosis. Cell Death Differ. 2004 Oct;11(10):1133-45. PubMed PMID: 15181455.
  • Conti F, Alessandri C, Bompane D, Bombardieri M, Spinelli FR, Rusconi AC, Valesini G. Autoantibody profile in systemic lupus erythematosus with psychiatric manifestations: a role for anti-endothelial-cell antibodies. Arthritis Res Ther.  2004;6(4):R366-72. Epub 2004 Jun 17. PubMed PMID: 15225372.
  • Alessandri C, Conti F, Valesini G. Role of anti-glial fibrillary acidic protein antibodies in the pathogenesis of neuropsychiatric systemic lupus erythematosus should be clarified: comment on the article by Trysberg et al. Arthritis Rheum. 2004 May;50(5):1698-9; author reply 1699. PubMed PMID: 15146449.
  • Ferro D, Pignatelli P, Loffredo L, Conti F, Valesini G, D'Angelo A, Violi F. Soluble CD154 plasma levels in patients with systemic lupus erythematosus: modulation by antiphospholipid antibodies. Arthritis Rheum. 2004 May;50(5):1693-4. PubMed PMID: 15146442.
  • De Carolis C, Greco E, Guarino MD, Perricone C, Dal Lago A, Giacomelli R, Fontana L, Perricone R. Anti-thyroid antibodies and antiphospholipid syndrome: evidence of reduced fecundity and of poor pregnancy outcome in recurrent spontaneous aborters. Am J Reprod Immunol. 2004 Oct;52(4):263-6. PMID: 15494047.
  • Morelli S, Bernardo ML, Viganego F, Sgreccia A, De Marzio P, Conti F, Priori  R, Valesini G. Left-sided heart valve abnormalities and risk of ischemic cerebrovascular accidents in patients with systemic lupus erythematosus. Lupus. 2003;12(11):805-12. PubMed PMID: 14667095.
  • Ferro D, Saliola M, Meroni PL, Valesini G, Caroselli C, Praticò D, Fitzgerald GA, Shoenfeld Y, Violi F. Enhanced monocyte expression of tissue factor by oxidative stress in patients with antiphospholipid antibodies: effect of antioxidant treatment. J Thromb Haemost. 2003 Mar;1(3):523-31. PubMed PMID:12871461.
  • Conti F, Sorice M, Circella A, Alessandri C, Pittoni V, Caronti B, Calderaro  C, Griggi T, Misasi R, Valesini G. Beta-2-glycoprotein I expression on monocytes  is increased in anti-phospholipid antibody syndrome and correlates with tissue factor expression. Clin Exp Immunol. 2003 Jun;132(3):509-16. PubMed PMID: 12780700.
  • Spadaro A, Scrivo R, Bombardieri M, Riccieri V, Rinaldi T, Taccari E, Valesini G. Relationship of interleukin-12 and interleukin-13 imbalance with class-specific rheumatoid factors and anticardiolipin antibodies in systemic lupus erythematosus. Clin Rheumatol. 2003 May;22(2):107-11. PubMed PMID: 12740674.
  • Pittoni V, Sorice M, Circella A, Cangemi R, Conti L, Ramenghi U, Gandolfo GM, Dianzani U, Valesini G. Specificity of antinuclear and antiphospholipid antibodies in sera of patients with autoimmune lymphoproliferative disease (ALD). Clin Exp Rheumatol. 2003 May-Jun;21(3):377-85. PubMed PMID: 12846062.
  • Ferro D, Iuliano L, Violi F, Valesini G, Conti F. Antioxidant treatment decreases the titer of circulating anticardiolipin antibodies: comment on the article by Sambo et al. Arthritis Rheum. 2002 Nov;46(11):3110-2. PubMed PMID: 12428268.
  • Spadaro A, Rinaldi T, Riccieri V, Taccari E, Valesini G. Interleukin-13 in autoimmune rheumatic diseases: relationship with the autoantibody profile. Clin Exp Rheumatol. 2002 Mar-Apr;20(2):213-6. PubMed PMID: 12051401.
  • Sorice M, Ferro D, Misasi R, Pittoni V, Longo A, Circella A, Garofalo T, Gradini R, Violi F, Gruenberg J, Valesini G. Evidence for anticoagulant activity  and beta2-GPI accumulation in late endosomes of endothelial cells induced by anti-LBPA antibodies. Thromb Haemost. 2002 Apr;87(4):735-41. PubMed PMID: 12008959.
  • Conti F, Priori R, Alessandri C, Spinelli FR, Medda E, Valesini G. Safety profile and causes of withdrawal due to adverse events in systemic lupus erythematosus patients treated long-term with cyclosporine A. Lupus. 2000;9(9):676-80. PubMed PMID: 11199922.
  • Sorice M, Pittoni V, Griggi T, Losardo A, Leri O, Magno MS, Misasi R, Valesini G. Specificity of anti-phospholipid antibodies in infectious mononucleosis: a role for anti-cofactor protein antibodies. Clin Exp Immunol. 2000 May;120(2):301-6. PubMed PMID: 10792380.
  • Sorice M, Circella A, Misasi R, Pittoni V, Garofalo T, Cirelli A, Pavan A, Pontieri GM, Valesini G. Cardiolipin on the surface of apoptotic cells as a possible trigger for antiphospholipids antibodies. Clin Exp Immunol. 2000 Nov;122(2):277-84. PubMed PMID: 11091286.
  • Shoenfeld Y, Alarcon-Segovia D, Buskila D, Abu-Shakra M, Lorber M, Sherer Y,  Berden J, Meroni PL, Valesini G, Koike T, Alarcon-Riquelme ME. Frontiers of SLE:  review of the 5th International Congress of Systemic Lupus Erythematosus, Cancun, Mexico, April 20-25, 1998. Semin Arthritis Rheum. 1999 Oct;29(2):112-30. PubMedPMID: 10553982.
  • Praticò D, Ferro D, Iuliano L, Rokach J, Conti F, Valesini G, FitzGerald GA,  Violi F. Ongoing prothrombotic state in patients with antiphospholipid antibodies: a role for increased lipid peroxidation. Blood. 1999 May 15;93(10):3401-7. PubMed PMID: 10233892.
  • Caronti B, Calderaro C, Alessandri C, Conti F, Tinghino R, Palladini G, Valesini G. Beta2-glycoprotein I (beta2-GPI) mRNA is expressed by several cell types involved in anti-phospholipid syndrome-related tissue damage. Clin Exp Immunol. 1999 Jan;115(1):214-9. PubMed PMID: 9933445.
  • Conti F, Priori R, Pittoni V, Pivetti-Pezzi P, Valesini G. Antiphospholipid antibodies and thrombosis. Lancet. 1999 Jul 3;354(9172):73. PubMed PMID: 10406389.
  • Caronti B, Calderaro C, Alessandri C, Conti F, Tinghino R, Pini C, Palladini  G, Valesini G. Serum anti-beta2-glycoprotein I antibodies from patients with antiphospholipid antibody syndrome bind central nervous system cells. J Autoimmun. 1998 Oct;11(5):425-9. PubMed PMID: 9802925.
  • Sorice M, Pittoni V, Circella A, Misasi R, Conti F, Longo A, Pontieri GM, Valesini G. Anti-prothrombin but not "pure" anti-cardiolipin antibodies are associated with the clinical features of the antiphospholipid antibody syndrome.  Thromb Haemost. 1998 Oct;80(4):713-5. PubMed PMID: 9799003.
  • Caronti B, Pittoni V, Palladini G, Valesini G. Anti-beta 2-glycoprotein I antibodies bind to central nervous system. J Neurol Sci. 1998 Apr 1;156(2):211-9. PubMed PMID: 9588860.
  • Iuliano L, Praticò D, Ferro D, Pittoni V, Valesini G, Lawson J, FitzGerald GA, Violi F. Enhanced lipid peroxidation in patients positive for antiphospholipid antibodies. Blood. 1997 Nov 15;90(10):3931-5. PubMed PMID: 9354660.
  • Ferro D, Pittoni V, Quintarelli C, Basili S, Saliola M, Caroselli C, Valesini G, Violi F. Coexistence of anti-phospholipid antibodies and endothelial perturbation in systemic lupus erythematosus patients with ongoing prothrombotic  state. Circulation. 1997 Mar 18;95(6):1425-32. PubMed PMID: 9118509.
  • Iuliano L, Praticò D, Ferro D, Pittoni V, Valesini G, Lawson J, FitzGerald GA, Violi F. Enhanced lipid peroxidation in patients positive for antiphospholipid antibodies. Blood. 1997 Nov 15;90(10):3931-5. PubMed PMID: 9354660.
  • Sorice M, Circella A, Griggi T, Garofalo T, Nicodemo G, Pittoni V, Pontieri GM, Lenti L, Valesini G. Anticardiolipin and anti-beta 2-GPI are two distinct populations of autoantibodies. Thromb Haemost. 1996 Feb;75(2):303-8. PubMed PMID: 8815581.
  • Morelli S, Perrone C, Valesini G. Tricuspid valve steno-insufficiency in systemic lupus erythematosus. Lupus. 1995 Aug;4(4):318-20. PubMed PMID: 8528231.
  • Balestrieri G, Tincani A, Spatola L, Allegri F, Prati E, Cattaneo R, Valesini G, Del Papa N, Meroni P. Anti-beta 2-glycoprotein I antibodies: a marker of antiphospholipid syndrome? Lupus. 1995 Apr;4(2):122-30. PubMed PMID: 7795615.
  • Violi F, Ferro D, Valesini G. Thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med. 1995 Sep 7;333(10):665; author reply 666-7. PubMed PMID: 7637735.
  • Violi F, Ferro D, Basili S, Artini M, Valesini G, Levrero M, Cordova C. Increased rate of thrombin generation in hepatitis C virus cirrhotic patients. Relationship to venous thrombosis. J Investig Med. 1995 Dec;43(6):550-4. PubMed PMID: 8605614.
  • Quintarelli C, Ferro D, Valesini G, Basili S, Tassone G, Violi F. Prevalence  of lupus anticoagulant in patients with cirrhosis: relationship with beta-2-glycoprotein I plasma levels. J Hepatol. 1994 Dec;21(6):1086-91. PubMed PMID: 7699232.
  • Blank M, Faden D, Tincani A, Kopolovic J, Goldberg I, Gilburd B, Allegri F, Balestrieri G, Valesini G, Shoenfeld Y. Immunization with anticardiolipin cofactor (beta-2-glycoprotein I) induces experimental antiphospholipid syndrome in naive mice. J Autoimmun. 1994 Aug;7(4):441-55. PubMed PMID: 7980847.
  • Cohen J, Bakimer R, Blank M, Valesini G, Shoenfeld Y. Pathogenic natural anti-cardiolipin antibodies: the experience from monoclonal gammopathy. Clin Exp  Immunol. 1994 Aug;97(2):181-6. PubMed PMID: 8050164.
  • Sorice M, Griggi T, Circella A, Garofalo T, d'Agostino F, Pittoni V, Pontieri GM, Lenti L, Valesini G. Detection of antiphospholipid antibodies by immunostaining on thin layer chromatography plates. J Immunol Methods. 1994 Jul 12;173(1):49-54. PubMed PMID: 8034985.
  • Ferro D, Quintarelli C, Valesini G, Violi F. Lupus anticoagulant and increased thrombin generation in patients with systemic lupus erythematosus. Blood. 1994 Jan 1;83(1):304. PubMed PMID: 8274747.
  • Valesini G, Priori R, Francia A, Balestrieri G, Tincani A, Airo P, Cattaneo R, Zambruni A, Troianello B, Chofflon M, et al. Central nervous system involvement in systemic lupus erythematosus: a new therapeutic approach with intrathecal dexamethasone and methotrexate. Springer Semin Immunopathol. 1994;16(2-3):313-21. PubMed PMID: 7716711.
  • Bragoni M, Di Piero V, Priori R, Valesini G, Lenzi GL. Sjögren's syndrome presenting as ischemic stroke. Stroke. 1994 Nov;25(11):2276-9. PubMed PMID: 7974556.
  • Caruso A, De Carolis S, Ferrazzani S, Valesini G, Caforio L, Mancuso S. Pregnancy outcome in relation to uterine artery flow velocity waveforms and clinical characteristics in women with antiphospholipid syndrome. Obstet Gynecol. 1993 Dec;82(6):970-7. PubMed PMID: 8233274.
  • Morelli S, Giordano M, De Marzio P, Priori R, Sgreccia A, Valesini G. Pulmonary arterial hypertension responsive to immunosuppressive therapy in systemic lupus erythematosus. Lupus. 1993 Dec;2(6):367-9. PubMed PMID: 8136819.
  • Brinciotti M, Ferrucci G, Trasatti G, Priori R, Squilloni E, Valesini G. Reflex seizures as initial manifestations of systemic lupus erythematosus in childhood. Lupus. 1993 Aug;2(4):281-3. PubMed PMID: 8268979.
  • Zurgil N, Bakimer R, Tincani A, Faden D, Cohen J, Lorber M, Valesini G, Shoenfeld Y. Detection of anti-phospholipid and anti-DNA antibodies and their idiotypes in newborns of mothers with anti-phospholipid syndrome and SLE. Lupus.  1993 Aug;2(4):233-7. PubMed PMID: 8268971.
  • Cohen J, Bakimer R, Blank M, Valesini G, Shoenfeld Y. Pathogenic serum IgG anticardiolipin antibodies and the idiotypic network. Ann Rheum Dis. 1993 Oct;52(10):742-8. PubMed PMID: 8257211; PubMed Central PMCID: PMC1005172.
  • Falco M, Sorrenti A, Priori R, Luan FL, Pittoni V, Agresti MG, Valesini G. Anti-cardiolipin antibodies in HIV infection are true antiphospholipids not associated with antiphospholipid syndrome. Ann Ital Med Int. 1993 Jul-Sep;8(3):171-4. PubMed PMID: 8217481.
  • Ferro D, Saliola M, Quintarelli C, Valesini G, Basili S, Grandilli AM, Bonavita MS, Violi F. Methods for detecting lupus anticoagulants and their relation to thrombosis and miscarriage in patients with systemic lupus erythematosus. J Clin Pathol. 1992 Apr;45(4):332-8. PubMed PMID: 1577971; PubMed  Central PMCID: PMC495275.
  • Valesini G, Shoenfeld Y. A new player in the antiphospholipid syndrome: the beta 2 glycoprotein I cofactor. Autoimmunity. 1992;14(2):105-10. Review. PubMed PMID: 1303677.
  • Krause I, Cohen J, Blank M, Bakimer R, Cartman A, Hohmann A, Valesini G, Asherson RA, Khamashta MA, Hughes GR, et al. Distribution of two common idiotypes of anticardiolipin antibodies in sera of patients with primary antiphospholipid syndrome, systemic lupus erythematosus and monoclonal gammopathies. Lupus. 1992 Feb;1(2):91-6. PubMed PMID: 1301969.
  • Ferro D, Saliola M, Quintarelli C, Carlucci M, Valesini G, Violi F. Specificity and sensitivity of diluted aPTT and anticardiolipin antibodies towards thrombosis and miscarriages in patients with systemic lupus erythematosus. Thromb Res. 1990 Aug 1;59(3):609-17. PubMed PMID: 2122546.
  • Violi F, Ferro D, Valesini G, Quintarelli C, Saliola M, Grandilli MA, Balsano F. Tissue plasminogen activator inhibitor in patients with systemic lupus erythematosus and thrombosis. BMJ. 1990 Apr 28;300(6732):1099-102. PubMed PMID: 2111722.
  • Violi F, Ferro D, Quintarelli C, Alessandri C, Saliola M, Valesini G, Balsano F. Dilute aPTT prolongation by antiphospholipid antibodies in patients with liver cirrhosis. Thromb Haemost. 1990 Apr 12;63(2):183-6. PubMed PMID: 2363119.
  • Valesini G, Priori R, Luan FL, Falco M, Balsano F. Amaurosis fugax and antiphospholipid antibodies. Lancet. 1990 Aug 11;336(8711):374. PubMed PMID: 1975351.
  • Valesini G, Violi F, Ferro D, Quintarelli C, Falco M, Tincani A, Balestrieri  G, Balsano F. Anticardiolipin antibodies possess anticoagulant activity which is  blocked by a monoclonal antibody against a cross reacting idiotype of antiphospholipid antibodies. Clin Exp Rheumatol. 1989 Nov-Dec;7(6):615-8. PubMed  PMID: 2515018.
  • Meroni PL, Tincani A, Harris EN, Valesini G, Hughes GR, Balestrieri G. The pathophysiology of anti-phospholipid antibodies. Clin Exp Rheumatol. 1989 Sep-Oct;7 Suppl 3:S81-4. Review. PubMed PMID: 2514060.
  • Ferro D, Quintarelli C, Russo G, Valesini G, Bonavita MS, Violi F. Successful removal of antiphospholipid antibodies using repeated plasma exchanges and prednisone. Clin Exp Rheumatol. 1989 Jan-Feb;7(1):103-4. PubMed PMID: 2706815.
  • Violi F, Ferro D, Valesini G, Quintarelli C, Balsano F. Lupus anticoagulant in liver cirrhosis. Thromb Haemost. 1988 Apr 8;59(2):335. PubMed PMID: 3133815.
  • el-Roeiy A, Valesini G, Friberg J, Shoenfeld Y, Kennedy RC, Tincani A, Balestrieri G, Gleicher N. Autoantibodies and common idiotypes in men and women with sperm antibodies. Am J Obstet Gynecol. 1988 Mar;158(3 Pt 1):596-603. PubMed  PMID: 3348322.
  • Valesini G, Tincani A, Harris EN, Mantelli PG, Allegri F, Palmieri G, Hughes  GR, Balsano F, Balestrieri G. Use of monoclonal antibodies to identify shared idiotypes on anticardiolipin and anti-DNA antibodies in human sera. Clin Exp Immunol. 1987 Oct;70(1):18-25. PubMed PMID: 3500812.
  • Violi F, Valesini G, Iuliano L, Ghiselli A, Falco M, Balsano F. Anticardiolipin antibodies and prostacyclin synthesis. Thromb Haemost. 1987 Jun 3;57(3):374. PubMed PMID: 3310320.
  • Violi F, Valesini G, Ferro D, Tincani A, Balestrieri G, Balsano F. Anticoagulant activity of anticardiolipin antibodies. Thromb Res. 1986 Nov 15;44(4):543-7. PubMed PMID: 3798414.
  • Passaleva A, Massai G, Emmi L, Stendardi L, Valesini G. Plasma exchange in the treatment of acute systemic lupus erythematosus without circulating immune complexes. Clin Exp Rheumatol. 1985 Jul-Sep;3(3):255-7. PubMed PMID: 2996812.
  • Valesini G, Pastore R, de Berardinis PG, Serafini U, Vincent A, Bottazzo GN.  Appearance of anti-acetylcholine receptor antibodies coincident with onset of myasthenic weakness in patient with systemic lupus erythematosus. Lancet. 1983 Apr 9;1(8328):831. PubMed PMID: 6132176.
public3.jpg